COMP <GO>
BHC vs UNH // FORWARD P/E MULTIPLE
Bausch Health Companies Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BHC 7
— UNH 6
▲ FORWARD P/E MULTIPLE LEADER: UNH
LAST: $8.02 (-2.19%) • MKT CAP: $3.00B
forward-pe
19.7x
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
forward-pe
17.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BHC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.60% | 12.38% | -4.78 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.5x | 15.3x | -4.77 | BHC | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | 6.25% | +15.75 | BHC | /fcf-yield <GO> |
| Operating Margin | 17.70% | 5.32% | +12.38 | BHC | /operating-margins <GO> |
| Net Profit Margin | 1.50% | 3.53% | -2.03 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | 3.33% | +3.37 | BHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 3.09 | -2.64 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | BHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.1 | 55.1 | +7.00 | BHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.33 | +0.64 | BHC | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 19.7x | 17.7x | +1.96 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.00B | $359.43B | -$356.43B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BHC REV | UNH REV | BHC GROSS % | UNH GROSS % | BHC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.27B | $447.57B | — | 88.7% | $1.00B | $16.07B |
| FY 2024 | $9.63B | $400.28B | — | 88.3% | $1.26B | $20.70B |
| FY 2023 | $8.76B | $371.62B | — | 89.6% | $637.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHC // BETA 0.97
UNH // BETA 0.33